Angelor
Venture capitalPre-Seed–Series A
Investment thesis
Angelor invests in French healthcare innovations, supporting companies from early spin-off stage through Series A once they have demonstrated medical and economic potential. It provides not only capital but also business and health-sector expertise, acting as a sparring partner to entrepreneurs with the help of an active community of experienced investors and mentors. The firm aims to accelerate the clinical, industrial and commercial scaling of innovations capable of improving patient health within five years, pursuing a dual goal of economic performance and medical progress. A portion of its carried interest is donated to health-focused associations.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 1 of 1 portfolio companiesAgTech ×1Climate Tech ×1FoodTech ×1
HQs:France×1
Investments · 1 tracked
founders shown can be your intro path
nextProtein breeds Black Soldier Fly larvae on unconsumed food to produce insect-based protein, oil and fertilizer used as ingredients in animal feed for aquaculture, poultry, pork and pet food.
AgTechClimate TechFoodTechParis, FR
Syrine Chaalala(Co-founder)inMohamed Gastli(Co-founder)in
Co-investorsKima VenturesAnaxagoBritish International InvestmentMirovaRAISE
Portfolio news
latest coverage across their companiesnextProtein · feedandadditive.com · Nov 7, 2025
Frequently asked questions
- What stage does Angelor invest at?
- Angelor invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Angelor focus on?
- Angelor focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Serendipity Impact VC is an early-stage venture firm backing founders building breakthrough technologies focused exclusively on mental and neuro health.
The Dementia Discovery Fund (DDF), managed by SV Health Investors, is a family of specialized venture capital funds investing exclusively in companies developing or enabling novel therapeutics for dementia, including Alzheimer's Disease.